Strategies to Close the Gap From Cervical Cancer Diagnosis to Treatment in Botswana

This study is looking at different ways to help women in Botswana get timely treatment for cervical cancer. Researchers are testing four approaches: Clinic Outreach (where the lab contacts your clinic about results), Enhanced Outreach (where the lab contacts both your clinic and you directly), Low-Touch Strategy (text message reminders), and High-Touch Strategy (text message reminders plus phone support). The goal is to see which of these strategies helps women start treatment within 90 days of being diagnosed. You might be able to join if you are a woman aged 18 or older, have a new diagnosis of invasive cervical cancer confirmed by the National Health Laboratory in Botswana, and are a citizen of Botswana. The study aims to enroll 610 participants, but its current status is unclear.

Study design
This is an interventional study that will compare different strategies to improve timely cervical cancer treatment. It plans to include 610 participants.
What's involved
Not specified in the trial record.
Compensation
Not stated in the trial record.
Follow-up
The main goal is measured within 90 days of joining the study.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT05952141

Strategies to Close the Gap From Cervical Cancer Diagnosis to Treatment in Botswana

Recruiting
NAAges 18+InterventionalHealth services
Abramson Cancer Center at Penn Medicine
~610 participants
Updated 2026-07-22 on ClinicalTrials.gov
What's tested:Clinic OutreachEnhanced OutreachLow-Touch StrategyHigh-Touch Strategy

At a glance

Recruiting sites
2 of 3 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Adoption
Measured over Within 90 days of randomization
Cervical Cancer
3 sites across 3 states
Pennsylvania1
North-East District1
Botswana1
  • Katharine Rendle, PhD,MSW,MPH · PRINCIPAL_INVESTIGATOR · University of Pennsylvania
  • Surbhi Grover, MD, MPH · PRINCIPAL_INVESTIGATOR · University of Pennsylvania

Opens a ready-to-send draft in your own email app — review before sending.

  • AdoptionWithin 90 days of randomization

    Defined as the initiation of cervical cancer treatment within 90 days of randomization.